BEGIN:VCALENDAR VERSION:2.0 METHOD:PUBLISH PRODID:-//Telerik Inc.//Sitefinity CMS 14.4//EN BEGIN:VTIMEZONE TZID:Central Standard Time BEGIN:STANDARD DTSTART:20231102T020000 RRULE:FREQ=YEARLY;BYDAY=1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=11 TZNAME:Central Standard Time TZOFFSETFROM:-0500 TZOFFSETTO:-0600 END:STANDARD BEGIN:DAYLIGHT DTSTART:20230301T020000 RRULE:FREQ=YEARLY;BYDAY=2SU;BYHOUR=2;BYMINUTE=0;BYMONTH=3 TZNAME:Central Daylight Time TZOFFSETFROM:-0600 TZOFFSETTO:-0500 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT DESCRIPTION:Department of Bioethics and Health HumanitiesSamuel G. Dunn Lec tureship in the Medical HumanitiesandDepartment of Global Health and Emerg ing DiseaseSummer Seminar Series&ldquo\;Omicron is Mild&rdquo\;: Sociopoli tical Use andMisuse of Infectious Diseases in the Era ofPathogen GenomicsS anghyuk Shin\, PhDAssociate Professor\, Sue &\; Bill Gross School of Nu rsingDirector\, UCI Infectious Disease Science InitiativeUniversity of Cal ifornia\, IrvineThursday\, June 15\, 202312:00-1:00pmRoom 3.201 Health Edu cation CenterORRegister for Zoom HERELunch provided\, first come first ser vedQuestions\, please email: bhh@utmb.eduRecent advances in infectious dis ease genomic science have led to an explosion of scientific knowledge abou t infectious disease virulence\, transmission\, and treatment. For example \, unprecedented sequencing and rapid genomic analysis of SARS-CoV-2 have enabled early detection of emerging variants with profound public health a nd societal implications. Genomic surveillance has also led to the detecti on of emerging tuberculosis strains that are resistant to multiple drugs\, including new drugs that have only recently been deployed. Moreover\, gen omic epidemiology allows detection of transmission &ldquo\;hot spots&rdquo \;\, &ldquo\;super-spreaders&rdquo\;\, and &ldquo\;super-spreading events& rdquo\; for numerous infectious diseases\, including COVID-19\, tuberculos is\, and HIV. These methods have become indispensable for outbreak investi gations\, by providing a genetic footprint for transmission histories of i nfectious diseases. However\, the rapid deployment of infectious disease g enomic science has not been followed by sufficient analysis and discussion of public engagement and societal impact of these promising scientific de velopments. In particular\, social and political actors have leveraged the emerging public knowledge and discourse around pathogen genomics (e.g. CO VID variants) to advance their aims\, including weakening of public health measures\, stigmatization and overpolicing of marginalized groups\, and g eopolitical posturing against foreign policy targets\, such as China. In t his lecture\, I will explore these emerging dynamics situated within the c ontext of a long history of the use of infectious disease threats for soci opolitical aims in the United States. My lecture will be from a perspectiv e of a genomic epidemiologist and public health scientist\, with a focus o n strategies for scientists to minimize harms that could arise from the mi suse of pathogen genomic knowledge. DTEND:20230615T180000Z DTSTAMP:20240328T142846Z DTSTART:20230615T170000Z LOCATION: SEQUENCE:0 SUMMARY:“Omicron is Mild”: Sociopolitical Use and Misuse of Infectious Dise ases in the Era of Pathogen Genomics UID:RFCALITEM638472149260980752 X-ALT-DESC;FMTTYPE=text/html:
Sanghyuk Shin\, PhD
Associate Professor\, Sue &\; Bill Gross School of Nursing
Director\, UCI Infectious Disease Science Initiative
University of Ca
lifornia\, Irvine
Questions\, please email: bhh@utmb.edu
Recent advances in infectious disease genomic science have l ed to an explosion of scientific knowledge about infectious disease virule nce\, transmission\, and treatment. For example\, unprecedented sequencing and rapid genomic analysis of SARS-CoV-2 have enabled early detection of emerging variants with profound public health and societal implications. G enomic surveillance has also led to the detection of emerging tuberculosis strains that are resistant to multiple drugs\, including new drugs that h ave only recently been deployed. Moreover\, genomic epidemiology allows de tection of transmission &ldquo\;hot spots&rdquo\;\, &ldquo\;super-spreader s&rdquo\;\, and &ldquo\;super-spreading events&rdquo\; for numerous infect ious diseases\, including COVID-19\, tuberculosis\, and HIV. These methods have become indispensable for outbreak investigations\, by providing a ge netic footprint for transmission histories of infectious diseases. However \, the rapid deployment of infectious disease genomic science has not been followed by sufficient analysis and discussion of public engagement and s ocietal impact of these promising scientific developments. In particular\, social and political actors have leveraged the emerging public knowledge and discourse around pathogen genomics (e.g. COVID variants) to advance th eir aims\, including weakening of public health measures\, stigmatization and overpolicing of marginalized groups\, and geopolitical posturing again st foreign policy targets\, such as China. In this lecture\, I will explor e these emerging dynamics situated within the context of a long history of the use of infectious disease threats for sociopolitical aims in the Unit ed States. My lecture will be from a perspective of a genomic epidemiologi st and public health scientist\, with a focus on strategies for scientists to minimize harms that could arise from the misuse of pathogen genomic kn owledge.
END:VEVENT END:VCALENDAR